Europe Digital Diabetes Management Market worth $12.53 billion by 2031
The report "Europe Digital Diabetes Management Market by Product (Device (CGM, Smart Glucometer, Insulin Patch Pump), Diabetes Apps, Service, Software & Platforms), Device Type (Handheld & Wearables), End User- Global Forecast to 2031" is projected to grow from USD 7.78 billion in 2026 and to reach USD 12.53 billion by 2031, at a Compound Annual Growth Rate (CAGR) of 10.0% during the forecast period.
Browse 150 market data Tables and 50 Figures spread through 200 Pages and in-depth TOC on "Europe Digital Diabetes Management Market by Product (Device (CGM, Smart Glucometer, Insulin Patch Pump), Diabetes Apps, Service, Software & Platforms), Device Type (Handheld & Wearables), End User- Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/europe-digital-diabetes-management-market-256216297.html
There is a rapid adoption of continuous glucose sensors, smart insulin pens, and connected blood glucose meters in Europe. This is enabling the transition to digital diabetes management. Such devices yield continuous real-time data, which can be integrated into digital platforms for monitoring, alerts, and bespoke insights. In many European countries, CGM systems are reimbursed for a specific group of patients, thus enhancing penetration of the device. As hardware adoption increases, the need for software platforms that can aggregate glucose data, analyze it, and make it interpretable increases, too. This synergy of devices and software manages diabetes by transitioning from episodic data points in time measurement to a continuous, data-driven approach.
The Continuous Glucose Monitoring (CGM) systems subsegment of the devices type segment held the largest share of the Europe digital diabetes management market in 2025.
Sub-segments of the products & devices taken into consideration in the digital diabetes management market include devices, digital diabetes management apps, data management software & platforms, and services. The devices segment includes CGM systems, smart insulin pens, smart insulin pumps/closed-loop systems, smart insulin patches, and smart glucose meters. The dominant market share of CGM systems in Europe allows players to leverage integration with national healthcare systems and reimbursement frameworks. By aligning CGM platforms with public diabetes management programs, electronic health records, and hospital procurement channels, manufacturers can scale adoption rapidly. Integration-driven volume growth strengthens long-term contracts, improves device standardization across regions, and creates barriers for new entrants, ensuring sustained revenue from institutional buyers.
The self/home healthcare segment of the end-user segment accounted for the largest share of the Europe digital diabetes management market in 2025.
Patients across Europe are increasingly turning toward self-monitoring solutions that can be accessed using flexible, private, and uncomplicated tools. Digital tools such as connected meters, combined with CGMs and mobile applications, can manage diabetes without the hassle of constant trips to a hospital. It increases adherence to treatment plans, which is more favorable and helpful in everyday decisions, and further accepts self/home healthcare over hospital care settings.
Germany is expected to exhibit the highest growth rate during the forecast period.
The Digital Healthcare Act (DVG) of Germany, along with the DiGA reimbursement scheme, encourages the speedy adoption of digital health solutions, including diabetes management solutions, as one of its eligible digital health applications. These approved digital health applications are reimbursed under statutory health insurance plans. This pathway reduces financial barriers for patients and providers, enabling increased adoption of digital diabetes platforms in Germany.
Key Market Players
Key players in this market are adopting several organic and inorganic growth strategies (such as product launches, agreements, collaborations, acquisitions, and expansions). Prominent players in this market include Medtronic (Ireland), B. Braun Melsungen AG (Germany), Dexcom, Inc. (US), Abbott Laboratories (US), F. Hoffmann-La Roche (Switzerland), Insulet Corporation (US), ARKRAY (Japan), ACON Laboratories, Inc. (US), Care Innovations, LLC (US), Health2Sync (Taiwan), Tandem Diabetes Care (US), Dottli (Finland), Ypsomed Holding AG (Switzerland), Emperra GmbH E-Health Technologies (Germany), Azumio (US), Ascensia Diabetes Care Holdings AG (Switzerland), LifeScan, Inc. (US), Tidepool (US), AgaMatrix (US), Glooko, Inc. (US), DarioHealth Corporation (Israel), Pendiq GmbH (Germany), One Drop (US), Decide Clinical Software GmbH (Austria), and BeatO (India).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Europe Digital Diabetes Management Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
